No statistically significant difference was seen for the primary endpoint ( NTSJ at week 52 ( 32.5 % vs 28.1 % [ adjusted OR 1.32 ( 0.56 to 3.09 ) , p = 0.522 ] ) in the MTX+ETN and MTX+PBO groups , respectively ) .